glp-1 therapies GLP-1-based for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Rethinking GLP-1RA Therapy Through the

The regulatory category, mechanism, and evidence standard are different from prescription drugs

Examples include: Semaglutide (Ozempic and Wegovy) Liraglutide (Saxenda and Victoza) Dulaglutide (Trulicity) These drugs: Help the body release insulin, but when blood sugar levels go up Lower glucagon levels to stop extra glucose from being made Slow down how fast the stomach empties so you feel full longer Curb hunger, which makes it easier to eat fewer calories When used with supervision, GLP-1 drugs like semaglutide may help people lose weight and manage metabolic health

Is this a necessary step for patient safety, or will it create a new barrier to access for those who have relied on these alternatives

Tip: Rotate injection sites to minimize irritation

Graeme Green Clarivate, London, UK

The first common stall window hits around months 3 to 5